GO:0004705 JUN kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004705 JUN kinase activity is a molecular function defined as the catalysis of JUN phosphorylation: JUN + ATP = JUN phosphate + ADP, activating JUN family transcription factors.
• The term is synonymous with c-Jun N-terminal kinase (JNK) activity, SAPK1, and JNK3alpha1, reflecting its role in stress-activated MAP kinase signaling.
• JUN kinase activity is stimulated by diverse extracellular cues including exercise, lysophosphatidylcholine, and LHRH agonists, as shown in human skeletal muscle and cancer cells.
• Constitutively active JNK fusion proteins, such as JNKK2-JNK1, demonstrate that JUN kinase activity directly drives c-Jun transcriptional activity.
• Dysregulated JUN kinase activity is implicated in cancer, cardiac hypertrophy, and metabolic stress responses, making it a target for mechanistic and therapeutic studies.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of JUN kinase signaling in disease and physiology.
Description
JUN kinase activity (GO:0004705) is a molecular function that catalyzes the phosphorylation and activation of members of the JUN family of nuclear transcription factors. This activity is synonymous with c-Jun N-terminal kinase (JNK) activity and is a key component of stress-activated MAP kinase signaling pathways. The reaction consumes ATP and transfers a phosphate group to JUN proteins, converting them into active transcription factors that regulate gene expression in response to extracellular stimuli. Researchers study JUN kinase activity because it links environmental stress, exercise, and hormonal signals to transcriptional programs controlling cell survival, proliferation, and metabolism. For example, exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in human skeletal muscle, while lysophosphatidylcholine activates JNK and activator protein 1. In cancer cells, LHRH agonists can stimulate JNK activity independently of protein kinase C. These findings establish JUN kinase activity as a central node in signal transduction, with broad relevance to physiology and disease.
JUN kinase activity At A Glance
| GO ID | GO:0004705 |
|---|---|
| GO term | JUN kinase activity |
| Ontology | molecular_function |
| Synonym | c-Jun N-terminal kinase activity, JNK, JNK3alpha1, SAPK1 |
| Definition | Catalysis of the reaction: JUN + ATP = JUN phosphate + ADP; phosphorylation and activation of JUN family transcription factors. |
| Major function | Phosphorylation and activation of JUN family transcription factors in response to stress and extracellular signals. |
| Reaction | JUN + ATP = JUN phosphate + ADP |
| Substrate | JUN family proteins |
| Cofactor | ATP (as phosphate donor) |
What Is GO:0004705?
According to the QuickGO definition, JUN kinase activity is the catalysis of the reaction: JUN + ATP = JUN phosphate + ADP. This reaction represents the phosphorylation and activation of members of the JUN family, a gene family that encodes nuclear transcription factors. In other words, it is an enzymatic activity that adds a phosphate group to JUN proteins using ATP, thereby turning them into active transcription factors. The term is classified under molecular_function and has synonyms including c-Jun N-terminal kinase activity, JNK, JNK3alpha1, and SAPK1.
Why Is JUN kinase activity Important in Cell Biology?
JUN kinase activity is important because it serves as a direct molecular link between extracellular stimuli and transcriptional reprogramming. By phosphorylating JUN proteins, this activity controls the activation of activator protein 1 (AP-1) complexes, which regulate genes involved in cell proliferation, differentiation, apoptosis, and stress responses. Experimental evidence shows that JUN kinase activity is stimulated by physiological exercise in human skeletal muscle, by lysophosphatidylcholine in cellular stress models, and by LHRH agonists in endometrial cancer cells. Moreover, constitutively active JNK fusion proteins demonstrate that JUN kinase activity is sufficient to stimulate c-Jun transcriptional activity. Dysregulation of this activity has been linked to pathological conditions including cancer and cardiac hypertrophy, making it a critical target for both basic research and therapeutic development.
• JUN kinase activity directly phosphorylates and activates JUN family transcription factors, driving AP-1-dependent gene expression.
• It is stimulated by exercise in human skeletal muscle, linking physical activity to transcriptional adaptation.
• Lysophosphatidylcholine activates JUN kinase activity, implicating it in lipid-mediated stress signaling.
• LHRH agonists stimulate JUN kinase activity in endometrial cancer cells, suggesting a role in hormone-responsive tumors.
• Constitutively active JNK fusion proteins show that JUN kinase activity is sufficient to stimulate c-Jun transcription.
• Antihypertrophic memory after regression of exercise-induced cardiac hypertrophy is mediated by a long noncoding RNA, highlighting JUN kinase-related pathways in cardiac remodeling.
• JUN kinase activity is a key node in stress-activated MAP kinase cascades that respond to cytokines, UV radiation, and oxidative stress.
• Dysregulated JUN kinase activity contributes to cancer progression and metabolic disorders, making it a potential therapeutic target.
• CRISPR-based models enable precise manipulation of JUN kinase genes to study their causal roles in disease.
• Understanding JUN kinase activity supports the development of inhibitors and activators for research and clinical applications.
What Happens During JUN kinase activity?
Substrate Recognition and Binding
In simple terms: The kinase first grabs onto the JUN protein it needs to modify.
JUN kinase activity begins with the specific recognition and binding of JUN family transcription factors as substrates. This interaction is mediated by docking motifs and kinase-substrate complementarity, ensuring that the kinase phosphorylates JUN proteins rather than unrelated targets. The binding step positions the JUN substrate for efficient phosphate transfer from ATP.
ATP-Dependent Phosphorylation
In simple terms: The kinase uses ATP to attach a phosphate group onto JUN.
The catalytic core of JUN kinase activity transfers the gamma-phosphate of ATP to specific serine or threonine residues within the JUN protein, producing JUN phosphate and ADP. This reaction is the defining biochemical event of GO:0004705 and is essential for converting JUN into an active transcription factor. The phosphorylation event is rapid and reversible, allowing dynamic regulation of JUN activity in response to cellular signals.
Activation of JUN Transcription Factors
In simple terms: Once phosphorylated, JUN becomes active and can turn on genes.
Phosphorylation of JUN proteins by JUN kinase activity leads to their activation as transcription factors. Activated JUN proteins form AP-1 complexes that bind to promoter and enhancer regions of target genes, thereby stimulating transcription. This step is critical for translating extracellular signals into changes in gene expression programs.
Signal Integration and Cellular Responses
In simple terms: This process helps cells respond to stress, exercise, and hormones.
JUN kinase activity integrates diverse extracellular stimuli, including exercise, lysophosphatidylcholine, and LHRH agonists, into transcriptional outputs. In human skeletal muscle, exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity, demonstrating physiological regulation. In cancer cells, LHRH agonists activate JNK independently of protein kinase C, highlighting context-dependent signaling. These responses contribute to cell survival, proliferation, and stress adaptation.
Key Genes Involved in GO:0004705 JUN kinase activity
The following genes and proteins are directly involved in or regulated by JUN kinase activity (GO:0004705), based on published experimental evidence.
| Gene | Major Role | Research Relevance |
|---|---|---|
| JUN | Substrate of JUN kinase activity; phosphorylated to become active transcription factor | Central to AP-1-dependent gene expression; studied in cancer and stress responses |
| JNK1 (MAPK8) | Mitogen-activated protein kinase that phosphorylates JUN | Key enzyme for JUN kinase activity; targeted in knockout and point-mutation studies |
| JNK2 (MAPK9) | Mitogen-activated protein kinase that phosphorylates JUN | Contributes to JUN kinase activity in stress and immune signaling |
| JNK3 (MAPK10) | Neuronal JNK isoform that phosphorylates JUN | Implicated in neurodegeneration and neuronal stress responses |
| JNKK2 (MAP2K7) | Upstream kinase that activates JNK | Used in constitutively active JNKK2-JNK1 fusion proteins to study JUN kinase activity |
| ATP | Phosphate donor for the phosphorylation reaction | Essential cofactor; its availability affects JUN kinase activity |
| AP-1 complex | Transcription factor complex containing phosphorylated JUN | Mediates downstream gene expression changes |
| LHRH receptor | G-protein coupled receptor that can stimulate JNK activity | Studied in endometrial cancer cells for hormone-driven JUN kinase activation |
| Lysophosphatidylcholine | Lipid mediator that stimulates JUN kinase activity | Used to induce JNK signaling in cellular stress models |
| Mhrt779 | Long noncoding RNA mediating antihypertrophic memory | Linked to JUN kinase-related pathways in cardiac hypertrophy regression |
| AMPKα2 | Metabolic kinase modulated by dietary timing and exercise | Potential crosstalk with JUN kinase signaling in muscle |
| Betaine | Exercise mimetic for geroprotection | May influence stress kinase pathways including JUN kinase |
| Clonal haematopoiesis genes | Mutated genes affecting sleep and exercise responses | Context for JUN kinase activity in blood cell stress responses |
| c-Jun | Protein product of JUN gene; substrate of JNK | Direct readout of JUN kinase activity in transcription assays |
| SAPK1 | Synonym for JNK; stress-activated protein kinase | Alternative name for JUN kinase activity |
| JNK3alpha1 | Splice variant of JNK3 | Synonym for JUN kinase activity; studied in neuronal contexts |
How Is JUN kinase activity Regulated?
JUN kinase activity is regulated at multiple levels. Upstream MAP kinase kinases, such as JNKK2, phosphorylate and activate JNK, which in turn phosphorylates JUN. Extracellular stimuli including exercise, lysophosphatidylcholine, and LHRH agonists can stimulate JUN kinase activity through distinct signaling pathways. For example, LHRH agonist-induced JNK activation in endometrial cancer cells occurs independently of protein kinase C, indicating alternative regulatory inputs. Constitutively active JNKK2-JNK1 fusion proteins demonstrate that bypassing upstream regulation is sufficient to drive c-Jun transcriptional activity. Additionally, long noncoding RNAs such as Mhrt779 can mediate antihypertrophic memory after regression of exercise-induced cardiac hypertrophy, suggesting epigenetic or RNA-based regulation of JUN kinase-related pathways. Metabolic signals, including AMPKα2 and dietary timing, may also modulate stress kinase activity in muscle. Together, these mechanisms ensure that JUN kinase activity is tightly controlled in response to physiological and pathological cues.
JUN kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| JUN | Cancer (endometrial, others); AP-1-driven proliferation | Knockout or point-mutation of JUN phosphorylation sites in cancer cell lines |
| JNK1 (MAPK8) | Metabolic stress, exercise adaptation | Knockout mice or CRISPR KO in skeletal muscle cells |
| JNK3 (MAPK10) | Neurodegeneration, neuronal stress | Knock-in of disease-associated variants in neuronal cultures |
| Mhrt779 | Cardiac hypertrophy and antihypertrophic memory | Overexpression or knockout of Mhrt779 in cardiomyocytes |
| AMPKα2 | Metabolic disorders, exercise response | Point-mutation knock-in in adipocytes or muscle cells |
JUN Kinase Activity in Cancer
JUN kinase activity is implicated in cancer biology through its role in activating AP-1 transcription factors that promote cell proliferation and survival. In human endometrial cancer cells, LHRH agonists stimulate JNK activity and AP-1 independently of protein kinase C, suggesting a hormone-driven mechanism that could contribute to tumor progression. Lysophosphatidylcholine, a lipid associated with inflammation and cancer, also stimulates JUN kinase activity and AP-1. These findings support the investigation of JUN kinase inhibitors as potential anticancer agents, although further studies are needed to define context-specific effects.
JUN Kinase Activity in Cardiac Hypertrophy
Exercise-induced physiological myocardial hypertrophy can regress, but an antihypertrophic memory persists that is mediated by the long noncoding RNA Mhrt779. This memory mechanism involves JUN kinase-related signaling pathways, as JNK activity is known to influence cardiac remodeling. Understanding how JUN kinase activity contributes to cardiac hypertrophy and its regression may inform therapeutic strategies for heart failure and pathological remodeling.
JUN Kinase Activity in Metabolic and Stress Responses
JUN kinase activity is stimulated by exercise in human skeletal muscle, linking it to metabolic adaptation and stress responses. Dietary timing and adipocyte AMPKα2 signaling modulate fat-muscle crosstalk during exercise, which may intersect with JUN kinase pathways. Betaine, an exercise mimetic, has been shown to promote geroprotection, potentially through stress kinase modulation. These observations suggest that JUN kinase activity is part of a broader network integrating exercise, nutrition, and aging.
From JUN kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of JUN kinase activity reduce AP-1 target gene expression? | CRISPR knockout of JNK1/2/3 in cell lines followed by RNA-seq |
| Which phosphorylation sites on JUN are critical for activation? | Point-mutation knock-in of serine-to-alanine substitutions in JUN |
| Can a constitutively active JNK fusion protein drive c-Jun transcription? | Knock-in of JNKK2-JNK1 fusion construct |
| How does exercise-induced JUN kinase activity affect muscle gene expression? | Overexpression of tagged JNK in human skeletal muscle cells |
| What is the role of Mhrt779 in cardiac hypertrophy via JUN kinase? | Knockout and overexpression of Mhrt779 in cardiomyocytes |
| Does LHRH agonist stimulation require JNK for AP-1 activation? | Knockout of JNK in endometrial cancer cells treated with triptorelin |
How to Study the JUN kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Phosphorylation of JUN by JNK | Validation of JUN kinase activity in recombinant systems |
| Western blot with phospho-JUN antibodies | Levels of phosphorylated JUN in cells | Monitoring JUN kinase activity after exercise or drug treatment |
| Luciferase reporter assay | AP-1 or c-Jun transcriptional activity | Testing constitutively active JNK constructs |
| Phosphoproteomics | Global phosphorylation changes | Identifying novel JUN kinase substrates |
| RNA-seq | Gene expression changes | Profiling AP-1 target genes after JNK activation |
| CRISPR knockout screening | Genes required for JUN kinase activity | Discovering regulators of JNK signaling |
| ChIP-seq | JUN binding sites on chromatin | Mapping AP-1 occupancy after JUN phosphorylation |
| Immunofluorescence | Subcellular localization of JUN and JNK | Visualizing nuclear translocation of activated JUN |
Kinase Activity Assays
JUN kinase activity can be measured using in vitro kinase assays with recombinant JUN as substrate and ATP as phosphate donor. These assays detect the transfer of radiolabeled phosphate or use phospho-specific antibodies against phosphorylated JUN. Such methods are essential for validating CRISPR models and testing inhibitors.
Transcriptional Reporter Assays
Because JUN kinase activity activates JUN transcription factors, AP-1 or c-Jun luciferase reporters can be used to monitor downstream transcriptional output. These assays are particularly useful for studying constitutively active JNK fusion proteins and for screening compounds that modulate JUN kinase activity.
Phospho-Proteomics and Western Blotting
Phospho-specific antibodies against JUN (e.g., phospho-Ser63/73) enable detection of JUN kinase activity in cell lysates by Western blotting. Mass spectrometry-based phosphoproteomics can globally map JUN phosphorylation sites and identify additional substrates. These approaches are valuable for comparing wild-type and CRISPR-edited cells.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate JUN kinase activity and downstream transcriptional programs. Bioinformatics analysis of RNA-seq and ChIP-seq data reveals AP-1 target networks and pathways affected by JUN kinase activity. These methods accelerate the discovery of therapeutic targets and biomarkers.
How CRISPR Can Be Used to Study GO:0004705 JUN kinase activity
Knockout
CRISPR knockout of JNK genes (MAPK8, MAPK9, MAPK10) or JUN itself can abolish JUN kinase activity, enabling loss-of-function studies. Knockout cell models are used to determine whether JUN phosphorylation is required for specific transcriptional responses to exercise, hormones, or stress. These models also help validate inhibitor specificity and identify compensatory pathways.
Point Mutation
Point mutations can be introduced into the JUN gene to replace key phosphorylation sites (e.g., serine to alanine), preventing JUN kinase-mediated activation while preserving protein expression. Such knock-in models are valuable for dissecting the contribution of individual phosphosites to AP-1 target gene expression. They also allow study of kinase-substrate specificity without confounding effects of protein loss.
Knock-in
Knock-in of tagged JNK or JUN alleles (e.g., FLAG, HA, or fluorescent tags) enables affinity purification and imaging of JUN kinase complexes. Knock-in of constitutively active JNKK2-JNK1 fusion proteins can mimic persistent JUN kinase activity, providing gain-of-function models. These approaches are useful for studying dynamic signaling in live cells and tissues.
Overexpression
Overexpression of wild-type or mutant JNK/JUN in cell lines or animal models can amplify JUN kinase activity and downstream transcriptional outputs. Overexpression models are particularly useful for testing whether increased JUN kinase activity is sufficient to drive phenotypes such as hypertrophy or proliferation. They also facilitate biochemical purification of JUN kinase complexes for structural and kinetic studies.
How EDITGENE Supports JUN kinase activity Research
Researchers studying JUN kinase activity-related genes often need to determine whether a candidate gene is causally involved in JUN phosphorylation, AP-1 activation, or downstream disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for JUN kinase activity research.
Frequently Asked Questions About JUN kinase activity
What is JUN kinase activity?
JUN kinase activity (GO:0004705) is the catalysis of the reaction JUN + ATP = JUN phosphate + ADP, which phosphorylates and activates JUN family transcription factors.
What genes are involved in JUN kinase activity?
Key genes include JUN (substrate), MAPK8 (JNK1), MAPK9 (JNK2), MAPK10 (JNK3), and MAP2K7 (JNKK2), which regulate or execute JUN phosphorylation.
What is another name for JUN kinase activity?
Common synonyms include c-Jun N-terminal kinase activity, JNK, JNK3alpha1, and SAPK1.
How is JUN kinase activity regulated?
It is regulated by upstream MAP kinase kinases such as JNKK2, extracellular stimuli like exercise and lysophosphatidylcholine, and hormonal signals such as LHRH agonists.
What diseases are associated with JUN kinase activity?
Dysregulated JUN kinase activity has been linked to cancer, cardiac hypertrophy, and metabolic stress responses.
How can I study JUN kinase activity in the lab?
Common methods include in vitro kinase assays, phospho-JUN Western blotting, luciferase reporter assays, phosphoproteomics, and CRISPR screens.
What is the role of JNK in exercise?
Exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in human skeletal muscle, linking JUN kinase activity to metabolic adaptation.
Can CRISPR be used to study JUN kinase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise manipulation of JNK and JUN genes to dissect their functions.
What is the JNKK2-JNK1 fusion protein?
It is a constitutively active c-Jun kinase that stimulates c-Jun transcriptional activity, used to study JUN kinase activity independently of upstream signals.
Why is JUN kinase activity important for cancer research?
It activates AP-1 transcription factors that promote proliferation and survival; LHRH agonists stimulate JNK in endometrial cancer cells, suggesting therapeutic relevance.
Conclusion
JUN kinase activity (GO:0004705) is a fundamental molecular function that phosphorylates and activates JUN family transcription factors, thereby converting extracellular signals into changes in gene expression. Its roles in exercise adaptation, cancer, cardiac hypertrophy, and stress responses make it a high-priority target for basic and translational research. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, provide powerful tools to dissect the causal roles of JUN kinase pathway components. By combining these models with kinase assays, transcriptomics, and bioinformatics, researchers can accelerate the discovery of mechanism-based therapeutics.
References
- 1. Geng L et al.. 2025. Systematic profiling reveals betaine as an exercise mimetic for geroprotection.. Cell 188(19):5403-5425.e33 PMID: 40570836
- 2. Chen J et al.. 2025. Dietary timing enhances exercise by modulating fat-muscle crosstalk via adipocyte AMPKα2 signaling.. Cell Metab 37(6):1364-1380.e6 PMID: 40088888
- 3. Gerhardt T et al.. 2026. Mutation-dependent responses to sleep and exercise in clonal haematopoiesis.. Nature 655(8125):1309-1319 PMID: 42271062
- 4. Gründker C et al.. 2001. Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin.. Eur J Endocrinol 145(5):651-8 PMID: 11720885
- 5. Aronson D et al.. 1998. Exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in human skeletal muscle.. Biochem Biophys Res Commun 251(1):106-10 PMID: 9790915
- 6. Zheng C et al.. 1999. The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity.. J Biol Chem 274(41):28966-71 PMID: 10506143
- 7. Lin H et al.. 2021. Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779.. Circulation 143(23):2277-2292 PMID: 33757294
- 8. Fang X et al.. 1997. Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity.. J Biol Chem 272(21):13683-9 PMID: 9153219
